Want to join the conversation?
Provider of drug delivery technology $CTLT saw lower profit during 4Q16 due to the release of a valuation allowance on deferred tax assets of $136.7MM recorded as a tax benefit in 4Q15. Net income fell to $58.1MM, or $0.46 per diluted share vs. $153.7MM, or $1.22 per diluted share in 4Q15. Revenue rose 4% to $532.2MM as reported vs. 4Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?